Conference Proceedings

HIGH OVERALL RESPONSE RATE WITH THE BTK INHIBITOR BGB-3111 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: AN UPDATE ON SAFETY AND ACTIVITY

JF Seymour, S Opat, G Cull, J Trotman, D Gottlieb, D Simpson, P Marlton, M Anderson, M Ku, DS Ritchie, S Ratnasingam, B Augustson, W Kim, L Wang, L Xue, J Hilger, J Huang, E Hedrick, AW Roberts, CS Tam

Hematological Oncology | Wiley | Published : 2017